Clinical Trials Browser

Phase 1/2 × Lymphoma, B-Cell × gossypol acetic acid × Clear all

NCT05338931 2022-05-26

Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Phase 1/2 Recruiting

Lymphoma, B-Cell